Expression of growth factors and their receptors in adamantinoma of long bones and the implication for its histogenesis.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 9582523)

Published in J Pathol on January 01, 1998

Authors

J V Bovée1, L J van den Broek, W I de Boer, P C Hogendoorn

Author Affiliations

1: Department of Pathology, Leiden University Medical Centre, The Netherlands.

Articles by these authors

Myxoid tumours of soft tissue. Histopathology (1999) 2.53

Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease. Thorax (2005) 1.99

Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis. J Pathol (1999) 1.81

EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. Am J Hum Genet (1999) 1.70

Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma. Lab Invest (2000) 1.62

Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation. Lung Cancer (2006) 1.61

Usefulness of radiography in differentiating enchondroma from central grade 1 chondrosarcoma. AJR Am J Roentgenol (1997) 1.61

The histopathological differential diagnosis of gastrointestinal stromal tumours. J Clin Pathol (2001) 1.60

Chondrosarcoma of the phalanx: a locally aggressive lesion with minimal metastatic potential: a report of 35 cases and a review of the literature. Cancer (1999) 1.54

Nora's lesion, a distinct radiological entity? Skeletal Radiol (2006) 1.52

Loss of heterozygosity and DNA ploidy point to a diverging genetic mechanism in the origin of peripheral and central chondrosarcoma. Genes Chromosomes Cancer (1999) 1.37

High quality RNA isolation from tumours with low cellularity and high extracellular matrix component for cDNA microarrays: application to chondrosarcoma. J Clin Pathol (2001) 1.33

Primary non-Hodgkin's lymphoma of bone: a clinicopathological investigation of 60 cases. Leukemia (1999) 1.32

Adamantinoma of the long bones. A clinicopathological study of thirty-two patients with emphasis on histological subtype, precursor lesion, and biological behavior. J Bone Joint Surg Am (1994) 1.31

Cartilaginous tumors: fast contrast-enhanced MR imaging. Radiology (2000) 1.28

Chronic obstructive pulmonary disease: role of bronchiolar mast cells and macrophages. Am J Pathol (1997) 1.25

MR imaging of clear cell sarcoma (malignant melanoma of the soft parts): a multicenter correlative MRI-pathology study of 21 cases and literature review. Skeletal Radiol (2000) 1.21

Murine chronic graft-versus-host disease as a model for lupus nephritis. Am J Pathol (1988) 1.18

Adenocarcinoma arising within a tailgut cyst: clinicopathological description and follow up of an unusual case. J Clin Pathol (1999) 1.17

Retroperitoneal extraskeletal osteosarcoma. J Clin Pathol (2001) 1.14

Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery. AJR Am J Roentgenol (1995) 1.11

Regulation of SLPI and elafin release from bronchial epithelial cells by neutrophil defensins. Am J Physiol Lung Cell Mol Physiol (2000) 1.08

Tumor-associated eosinophilic infiltrate of cervical cancer is indicative for a less effective immune response. Hum Pathol (1996) 1.06

Cartilaginous tumors: correlation of gadolinium-enhanced MR imaging and histopathologic findings. Radiology (1993) 1.06

Near-haploidy and subsequent polyploidization characterize the progression of peripheral chondrosarcoma. Am J Pathol (2000) 1.05

Pathogenesis of experimental lupus nephritis: a role for anti-basement membrane and anti-tubular brush border antibodies in murine chronic graft-versus-host disease. Clin Exp Immunol (1990) 1.05

Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts). Br J Cancer (2001) 1.05

Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: A European Osteosarcoma Intergroup study. J Clin Oncol (1999) 1.05

[Imatinib, a specific tyrosine-kinase inhibitor, for the treatment of patients with a gastrointestinal stroma cell tumor]. Ned Tijdschr Geneeskd (2003) 1.04

Musculoskeletal tumors: does fast dynamic contrast-enhanced subtraction MR imaging contribute to the characterization? Radiology (1998) 1.03

Accuracy of the Jamshidi trocar biopsy in the diagnosis of bone tumors. Clin Orthop Relat Res (1997) 1.03

Preoperative evaluation and monitoring chemotherapy in patients with high-grade osteogenic and Ewing's sarcoma: review of current imaging modalities. Skeletal Radiol (1998) 1.02

Tobacco use in relation to COPD and asthma. Eur Respir J (2007) 1.02

Clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts) and cutaneous melanoma: exploring the histogenetic relationship between these two clinicopathological entities. J Pathol (1998) 1.02

Lymph node staging standards in gastric cancer. J Clin Oncol (1995) 1.01

Cytogenetic analysis of adamantinoma of long bones: further indications for a common histogenesis with osteofibrous dysplasia. Cancer Genet Cytogenet (1997) 1.00

The extracellular matrix in pathology. J Lab Clin Med (1988) 0.99

Human granzyme B mediates cartilage proteoglycan degradation and is expressed at the invasive front of the synovium in rheumatoid arthritis. Rheumatology (Oxford) (2001) 0.98

Immunostaining of chain-specific keratins on formalin-fixed, paraffin-embedded tissues: a comparison of various antigen retrieval systems using microwave heating and proteolytic pre-treatments. J Histochem Cytochem (1995) 0.98

Soft tissue tumours of the retroperitoneum. Sarcoma (2000) 0.97

Chromosome 9 alterations and trisomy 22 in central chondrosarcoma: a cytogenetic and DNA flow cytometric analysis of chondrosarcoma subtypes. Diagn Mol Pathol (2001) 0.96

Malignant progression in multiple enchondromatosis (Ollier's disease): an autopsy-based molecular genetic study. Hum Pathol (2000) 0.95

Characterization and in vivo transfer of nephritogenic autoantibodies directed against dipeptidyl peptidase IV and laminin in experimental lupus nephritis. Lab Invest (1990) 0.94

Localization of gamma-glutamylcysteine synthetase messenger rna expression in lungs of smokers and patients with chronic obstructive pulmonary disease. Free Radic Biol Med (2000) 0.92

Retain or sacrifice the posterior cruciate ligament in total knee arthroplasty? A histopathological study of the cruciate ligament in osteoarthritic and rheumatoid disease. J Clin Pathol (2001) 0.92

A phase II study of cisplatin, ifosfamide and doxorubicin in operable primary, axial skeletal and metastatic osteosarcoma. European Osteosarcoma Intergroup (EOI). Ann Oncol (1999) 0.91

Re. Review article entitled 'The neoplastic pathogenesis of solitary and multiple osteochondromas'. J Pathol (2000) 0.90

Dynamic contrast-enhanced MR imaging of musculoskeletal tumors: basic principles and clinical applications. J Magn Reson Imaging (1997) 0.90

Can MRI predict the histopathological response in patients with osteosarcoma after the first cycle of chemotherapy? Clin Radiol (1995) 0.90

Adamantinoma of the long bones: keratin subclass immunoreactivity pattern with reference to its histogenesis. Am J Surg Pathol (1993) 0.89

MR imaging based strategies in limb salvage surgery for osteosarcoma of the distal femur. Skeletal Radiol (1997) 0.89

Late malignant transformation of a benign giant-cell tumor of bone. A case report. J Bone Joint Surg Am (1997) 0.89

Diagnostic and prognostic implications of the unfolding molecular biology of bone and soft tissue tumours. J Clin Pathol (1999) 0.88

Primary intraosseous manifestation of Rosai-Dorfman disease: 2 cases and review of literature. JBR-BTR (2014) 0.87

Local recurrence of a phyllodes tumour of the breast presenting with widespread differentiation to a telangiectatic osteosarcoma. J Clin Pathol (1998) 0.85

Functions of epidermal growth factor-like growth factors during human urothelial reepithelialization in vitro and the role of erbB2. Urol Res (2002) 0.85

Keratin immunoreactivity in melanoma of soft parts (clear cell sarcoma). Histopathology (1995) 0.85

Amyloid beta precursor protein-mRNA is expressed throughout cerebral vessel walls. Brain Res (1999) 0.84

Synovial sarcoma: dynamic contrast-enhanced MR imaging features. Skeletal Radiol (2001) 0.83

Monitoring the effect of chemotherapy in Ewing's sarcoma of bone with MR imaging. Skeletal Radiol (1994) 0.82

Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance. Br J Cancer (1998) 0.82

Transforming growth factor-beta(1), -beta(2), -beta(3), basic fibroblast growth factor and vascular endothelial growth factor expression in keratinocytes of burn scars. Eur Cytokine Netw (2000) 0.82

Absence of Epstein-Barr virus (EBV) in a gastrointestinal stromal cell tumour (GIST) in an adult human immunodeficiency virus-seropositive patient with past EBV infection. Eur J Gastroenterol Hepatol (1997) 0.82

Adamantinoma-like Ewing's sarcoma and Ewing's-like adamantinoma. The t(11; 22), t(21; 22) status. J Pathol (2001) 0.82

Chondroblastic osteosarcoma: characterisation by gadolinium-enhanced MR imaging correlated with histopathology. Skeletal Radiol (1998) 0.82

Expression of transforming growth factor beta1 and its receptors in normal human urothelium and human transitional cell carcinomas. Hum Pathol (1999) 0.82

How is the mutational status for tumor suppressors p53 and p16(INK4A) in MFH of the bone? Cancer Lett (1998) 0.82

DNA aberrations in the epithelial cell component of adamantinoma of long bones. Am J Pathol (1995) 0.81

Malignant astrocytoma-derived region of common amplification in chromosomal band 17p12 is frequently amplified in high-grade osteosarcomas. Genes Chromosomes Cancer (1997) 0.81

A possible role of CD46 for the protection in vivo of human renal tumor cells from complement-mediated damage. Lab Invest (2000) 0.81

An association between cartilaginous tumours and breast cancer in the national pathology registration in The Netherlands points towards a possible genetic trait. J Pathol (2001) 0.81

Detection of areas with viable remnant tumor in postchemotherapy patients with Ewing's sarcoma by dynamic contrast-enhanced MRI using pharmacokinetic modeling. Magn Reson Imaging (2000) 0.80

Skin metastases of osteogenic sarcoma: a case report with review of the literature. J Pediatr Hematol Oncol (1997) 0.80

Treatment of high-grade bone sarcomas with neoadjuvant chemotherapy: the utility of sequential color Doppler sonography in predicting histopathologic response. AJR Am J Roentgenol (1995) 0.80

Classification of histopathologic changes following chemotherapy in Ewing's sarcoma of bone. Skeletal Radiol (1994) 0.79

Induction and activity of several isoenzymes of cytochrome P-450 in primary cultures of rat hepatocytes, in comparison with in vivo data. Mol Toxicol (1989) 0.79

Human neutrophil defensins and secretory leukocyte proteinase inhibitor in squamous metaplastic epithelium of bronchial airways. Inflamm Res (2004) 0.79

Infantile-type digital fibromatosis tumour in an adult. Br J Dermatol (2000) 0.79

Unusual manifestations of Yersinia enterocolitica infections diagnosed using novel methods. Clin Infect Dis (1992) 0.78

Distribution of extracellular matrix components in adamantinoma of long bones suggests fibrous-to-epithelial transformation. Hum Pathol (1997) 0.78

Can conventional radiographs be used to monitor the effect of neoadjuvant chemotherapy in patients with osteogenic sarcoma? Skeletal Radiol (1996) 0.78

[Adamantinoma of the long bones: an anatomo-clinical review and its relationship with osteofibrous dysplasia]. Ann Pathol (2001) 0.77

Translocation (11;22)(q24;q12) in a small cell tumor of the thigh in a 2-year-old boy: immunohistology, cytogenetics, molecular genetics, and review of the literature. Hum Pathol (1999) 0.77

Does magnetic resonance imaging make a difference for patients with musculoskeletal sarcoma? Br J Radiol (1997) 0.77

The distribution of cellular adhesion molecules in pigmented skin lesions. Cancer (1994) 0.77

Identification of an EWS-pseudogene using translocation detection by RT-PCR in Ewing's sarcoma. Biochem Biophys Res Commun (1995) 0.77

Ring chromosome 4 as the sole cytogenetic anomaly in a chondroblastoma: a case report and review of the literature. Cancer Genet Cytogenet (1998) 0.77

Localization of the epitope of a monoclonal antibody against human insulin-like growth factor binding protein-1, functionally interfering with insulin-like growth factor binding. Growth Regul (1993) 0.76

Changes in tumor perfusion induced by chemotherapy in bone sarcomas: color Doppler flow imaging compared with contrast-enhanced MR imaging and three-phase bone scintigraphy. Radiology (1994) 0.76

Chondrosarcoma is not characterized by detectable telomerase activity. J Pathol (2001) 0.76

Bone tumors. Eur Radiol (2000) 0.75

Experimental myelocytic leukemia in the Brown-Norway rat as a model for pulmonary leukostasis. Am J Pathol (1991) 0.75

A novel rat mesangial matrix protein, MMP-50/100, involved in mesangial glomerulopathies. Lab Invest (1995) 0.75

Calcified meningioma of the skull base simulating chondrosarcoma. Eur J Radiol (1995) 0.75

Endothelial activation antigens in pulmonary leukostasis in leukemia. Acta Haematol (1993) 0.75